Figure 2.
Figure 2. Effect of the association of DOCK2 with ELMO1. The association of DOCK2 with ELMO1 is critical for DOCK2-mediated Rac activation and cytoskeletal reorganization. (A) The expression of DOCK2 or DOCK2delN in BEα16-3 (lane 1), N3-5 (lane 2), 17-11 (lane 3), 25-7 (lane 4), and 84-3 (lane 5) was analyzed with the use of anti-DOCK2 antibody. A nonspecific band (NS) is included as a loading control. (B) Cell extracts were prepared from BEα16-3 (lane 1), 25-7 (lane 2), and 84-3 (lane 3); immunoprecipitated with anti-HA affinity matrix (to precipitate DOCK2 or DOCK2delN); and analyzed by immunoblotting with anti-ELMO1 antibody (top panel), anti-CrkL antibody (middle panel), or anti-HA antibody (to detect DOCK2 or DOCK2delN) (bottom panel). The expression of ELMO1, CrkL, DOCK2, or DOCK2delN in each cell line is shown in the 3 right lanes of each subpanel. (C) Cell extracts were prepared from BEα16-3 (lane 1) and 17-11 (lane 2), immunoprecipitated with anti-CrkL antibody, and analyzed by immunoblotting with anti-DOCK2 antibody (top panel), anti-C3G antibody (middle panel), or anti-CrkL antibody (bottom panel). The expression of DOCK2, C3G, and CrkL in each cell line is shown in the 2 right lanes. (D) Cell extracts were prepared from 84-3 (lane 1), 17-11 (lane 2), and BEα16-3 (lane 3), and analyzed for Rac or for the GTP-bound, activated Rac by means of glutathione S-transferase (GST)–fusion, Rac-binding domain of p21-activated kinase 1 (PAK1). (E) BEα16-3, 17-11, and 84-3 were analyzed for actin polymerization by means of staining with phalloidin. The differential interference contrast (DIC) images are shown in the left panels. Original magnification, × 600. (F) NS1 (lane 1) and NS1 transfectant expressing ELMO1 (lane 2) were analyzed for Rac (bottom panel) or the GTP-bound, activated Rac (middle panel) as described in panel D. The expression of ELMO1 is shown in the top panel.

Effect of the association of DOCK2 with ELMO1. The association of DOCK2 with ELMO1 is critical for DOCK2-mediated Rac activation and cytoskeletal reorganization. (A) The expression of DOCK2 or DOCK2delN in BEα16-3 (lane 1), N3-5 (lane 2), 17-11 (lane 3), 25-7 (lane 4), and 84-3 (lane 5) was analyzed with the use of anti-DOCK2 antibody. A nonspecific band (NS) is included as a loading control. (B) Cell extracts were prepared from BEα16-3 (lane 1), 25-7 (lane 2), and 84-3 (lane 3); immunoprecipitated with anti-HA affinity matrix (to precipitate DOCK2 or DOCK2delN); and analyzed by immunoblotting with anti-ELMO1 antibody (top panel), anti-CrkL antibody (middle panel), or anti-HA antibody (to detect DOCK2 or DOCK2delN) (bottom panel). The expression of ELMO1, CrkL, DOCK2, or DOCK2delN in each cell line is shown in the 3 right lanes of each subpanel. (C) Cell extracts were prepared from BEα16-3 (lane 1) and 17-11 (lane 2), immunoprecipitated with anti-CrkL antibody, and analyzed by immunoblotting with anti-DOCK2 antibody (top panel), anti-C3G antibody (middle panel), or anti-CrkL antibody (bottom panel). The expression of DOCK2, C3G, and CrkL in each cell line is shown in the 2 right lanes. (D) Cell extracts were prepared from 84-3 (lane 1), 17-11 (lane 2), and BEα16-3 (lane 3), and analyzed for Rac or for the GTP-bound, activated Rac by means of glutathione S-transferase (GST)–fusion, Rac-binding domain of p21-activated kinase 1 (PAK1). (E) BEα16-3, 17-11, and 84-3 were analyzed for actin polymerization by means of staining with phalloidin. The differential interference contrast (DIC) images are shown in the left panels. Original magnification, × 600. (F) NS1 (lane 1) and NS1 transfectant expressing ELMO1 (lane 2) were analyzed for Rac (bottom panel) or the GTP-bound, activated Rac (middle panel) as described in panel D. The expression of ELMO1 is shown in the top panel.

Close Modal

or Create an Account

Close Modal
Close Modal